Localized Scleroderma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Localized Scleroderma

What is the definition of Localized Scleroderma?
Localized scleroderma is characterized by thickening of the skin from excessive collagen deposits. Collagen is a protein normally present in our skin that provides structural support. However, when too much collagen is made, the skin becomes stiff and hard. Localized types of scleroderma are those limited to the skin and related tissues and, in some cases, the muscle below. Internal organs are not affected by Localized scleroderma, and Localized scleroderma can never progress to the systemic form of the disease. Often, localized conditions improve or go away on their own over time, but the skin changes and damage that occur when the disease is active can be permanent. For some people, Localized scleroderma is serious and disabling. There are two generally recognized types of Localized scleroderma: morphea and linear.
What are the alternative names for Localized Scleroderma?
  • Localized scleroderma
  • Localized fibrosing scleroderma
  • Scleroderma, localized
Who are the top Localized Scleroderma Local Doctors?
Elite in Localized Scleroderma
Dermatology
Elite in Localized Scleroderma
Dermatology

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
Languages Spoken:
English

Heidi Jacobe is a Dermatologist in Dallas, Texas. Dr. Jacobe is rated as an Elite provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Localized Scleroderma, Scleroderma, Systemic Sclerosis (SSc), and Scleroma.

Elite in Localized Scleroderma
Dermatology
Elite in Localized Scleroderma
Dermatology

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
Languages Spoken:
English

Jack O'brien is a Dermatologist in Dallas, Texas. Dr. O'brien is rated as an Elite provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Localized Scleroderma, Hidradenitis Suppurativa, Cutaneous Lupus Erythematosus (CLE), and Scleroderma.

 
 
 
 
Learn about our expert tiers
Learn More
Kathryn S. Torok
Elite in Localized Scleroderma
Pediatric Rheumatology
Elite in Localized Scleroderma
Pediatric Rheumatology

UPMC Children's Hospital Of Pittsburgh, Pediatric Rheumatology

4401 Penn Avenue, Floor 3, 
Pittsburgh, PA 
Languages Spoken:
English

Kathryn Torok, MD, is a board-certified pediatric rheumatologist and director of the Pediatric Scleroderma Clinic at UPMC Children’s Hospital of Pittsburgh. Dr. Torok earned her medical degree from the Penn State College of Medicine. She began her career in pediatric rheumatology as a fellow at UPMC Children’s Hospital in 2006. Upon completion of her fellowship, she started as an instructor in the Division of Rheumatology at the University of Pittsburgh School of Medicine in July 2009 and was promoted to assistant professor in July 2010. Dr. Torok is rated as an Elite provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Localized Scleroderma, Systemic Sclerosis (SSc), Pulmonary Hypertension, and Hypertension.

What are the latest Localized Scleroderma Clinical Trials?
International Multicentre Cohort Study on Clinical Manifestations and Response to Therapy in Juvenile Onset Eosinophilic Fasciitis

Summary: Eosinophilic fasciitis is a connective tissue disorder characterized by inflammation of the muscle fasciae, which is very rare in children. In juvenile-onset eosinophilic fasciitis (JEF), there may be severe joint involvement and skin manifestations may be less prevalent than in adults. It represents an important differential diagnosis of both juvenile-onset systemic sclerosis and localized sclero...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach (BETY) in Children and Adults Diagnosed With Scleroderma: A Single-Blind Randomized Controlled Trial

Summary: This study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with scleroderma.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Localized Scleroderma?
Towards effective targeted therapies in morphea.
Tired of the same old research?
Check Latest Advances
RETRACTION: High-Frequency Ultrasound Evaluation of Morphea: Retrospective Analytical Study.